Clinical Trial Update: A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study [EARLY_Phase 1]

View source ↗

Summary

This entry describes an early Phase 1 pharmacokinetic study of a novel inhaled melatonin formulation for adults with insomnia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Inhaled melatonin formulation (melatonin)

Snippet

Sponsor: Woolcock Institute of Medical Research | Conditions: Insomnia | EARLY_Phase 1 | Status: RECRUITING